Ochsner Health System

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Ochsner Health System sits in the top decile of US sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count).

29 total trials 5 currently recruiting 18 completed top decile by trial count

Ochsner Health System: 29 sponsored US clinical trials, 5 recruiting.

Ochsner Health System sponsors 29 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 18 completed. 4 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pre-Eclampsia; Complicating Pregnancy, with 1 trials.

Top-decile sponsor footprint

Ochsner Health System ranks in the top decile of sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 35/100

18 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

29 total, page 1 of 1

RECRUITING NA

Cold and Compression After Rotator Cuff Repair (RCR)

NCT07516327

RECRUITING NA

Cold and Compression Post TKA

NCT07023185

RECRUITING NA

Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior

NCT07226973

RECRUITING NA

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

NCT06920563

RECRUITING NA

90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia

NCT05953961

NOT YET RECRUITING Phase 4

Colonoscopy and Antiplatelet Therapy Trial

NCT06613191

COMPLETED Phase 4

3D PET Myocardial Blood Flow and Rb82 Infusion Profiles

NCT05286593

COMPLETED Phase 2

Regional Anesthesia in Pediatric Orthopaedic Patients

NCT04669145

TERMINATED Phase 2

Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy

NCT04155099

COMPLETED NA

Efficacy of Virtual Reality in Pain Reduction in Orthopedic Pediatric Patients

NCT04901793

TERMINATED NA

Vertebral Body Tethering Treatment for Idiopathic Scoliosis

NCT03802656

COMPLETED NA

Opioid Treatment and Recovery Through a Safe Pain Management Program

NCT03889418

TERMINATED NA

Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix

NCT03752073

COMPLETED

Care EcoSystem: Ochsner Health System

NCT03916718

COMPLETED

Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

NCT03778372

TERMINATED

Dementia Management With Interactive Technology

NCT03916588

COMPLETED NA

Probiotics and Multi-Drug Resistant Urinary Tract Infection

NCT03644966

COMPLETED

Noninvasive Monitoring of Cerebral Blood Flow Autoregulation

NCT05170295

COMPLETED Phase 2

Xylitol for Chronic Sinusitis

NCT03229551

COMPLETED

KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

NCT03779282

COMPLETED

Transverse Thoracic Plane Block in the Pediatric Cardiac Patient

NCT04138745

COMPLETED Phase 4

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

NCT04781075

COMPLETED NA

Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts

NCT03169842

COMPLETED NA

A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients

NCT02360748

COMPLETED Phase 4

Total Intravenous Anesthesia in Sinus Surgery

NCT02578862

COMPLETED

Circulating Biomarkers and Ventricular Tachyarrhythmia

NCT01892462

COMPLETED NA

Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)

NCT01482169

TERMINATED NA

Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients

NCT00778063

COMPLETED Phase 2

Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure

NCT00651885

What is open in the Ochsner Health System pipeline

5 recruiting of 29 indexed (17% open); 18 completed (62%).

Phase mix: 4 late (III/IV) vs 4 early (I/II) (balanced across stages).

Top condition: Pre-Eclampsia; Complicating Pregnancy (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ochsner Health System: open-pipeline peers nationwide

Peers matched on 29 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Ochsner Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%20%40%60%80%100% Total trials Recruiting share Ochsner Health SystemBeOne MedicinesBioCryst PharmaceuticalsCalifornia Pacific Medical Center Research InstituteCenter for International Blood and Marrow Transplant ResearchHunter College of City University of New YorkBaylor Research InstituteSeattle Children's HospitalEmory University
Ochsner Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ochsner Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 29 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Ochsner Health System page

29 registered trials is a research-attention snapshot, not an endorsement of Ochsner Health System or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Ochsner Health System pipeline card: 29 registered trials from official public datasets.Report a data error.